RAMSEY, N.J. (AP) _ Adma Biologics Inc. (ADMA) on Friday reported a loss of $6.5 million in its first quarter.
The Ramsey, New Jersey-based company said it had a loss of 51 cents per share.
The infectious disease drug developer posted revenue of $2.6 million in the period.
In the final minutes of trading on Friday, the company's shares hit $4.37. A year ago, they were trading at $5.85.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMA at https://www.zacks.com/ap/ADMA
Keywords: Adma Biologics, Earnings Report